Y. Pirson

发表

Autosomal dominant polycystic kidney disease

Yves Pirson, V. Torres, P. Harris, 1992, The Lancet.

D. Wiebers, V. Torres, Y. Pirson, 2006, The New England journal of medicine.

Tamm-Horsfall protein or uromodulin: new ideas about an old molecule.

K. Dahan, O. Devuyst, Y. Pirson, 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Modifier effect of ENOS in autosomal dominant polycystic kidney disease.

J. Balligand, X. Lens, O. Devuyst, 2002, Human molecular genetics.

Significance of NS3 and NS5 antigens in screening for HCV antibody

M. Jadoul, C. V. Strihou, Y. Pirson, 1994, The Lancet.

Norfloxacin and cyclosporine--a safe combination.

M. Jadoul, Y. Pirson, C. van Ypersele de Strihou, 1989, Transplantation.

The interaction between clarithromycin and cyclosporine in kidney transplant recipients.

J. Squifflet, Y. Pirson, E. Goffin, 1994, Transplantation.

Significant rate of hepatitis B reactivation following kidney transplantation in patients with resolved infection.

Y. Pirson, E. Goffin, C. Beguin, 2012, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Tuberous sclerosis complex-associated kidney angiomyolipoma: from contemplation to action.

Y. Pirson, 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Increase of physical activity level after successful renal transplantation: a 5 year follow-up study.

T. Lejeune, J. Squifflet, T. Lejeune, 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Daily hemodialysis and nutritional status.

Y. Pirson, E. Goffin, T. Goovaerts, 2002, Kidney international.

Clinical and Genetic Spectra of Autosomal Dominant Tubulointerstitial Kidney Disease due to Mutations in UMOD and MUC1.

K. Dahan, T. Fehr, D. Gale, 2020, Kidney international.

Enos polymorphism and renal disease progression in autosomal dominant polycystic kidney disease.

X. Lens, O. Devuyst, D. Chauveau, 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Long-term effect of hbs antigenemia on patient survival after renal transplantation.

Y. Pirson, G. Alexandre, C. Ypersele, 1977, The New England journal of medicine.

Nephrology Dialysis Transplantation Outcome of renal replacement therapy in autosomal dominant polycystic kidney disease

Y. Pirson, E. Goffin, J. Christophe, 2005 .

Phenotype and outcome in hereditary tubulointerstitial nephritis secondary to UMOD mutations.

K. Dahan, C. Antignac, D. Lacombe, 2011, Clinical journal of the American Society of Nephrology : CJASN.

Recurrence of focal glomerulosclerosis despite cyclosporin treatment after renal transplantation.

J. Squifflet, Y. Pirson, E. Marbaix, 1986, British medical journal.

Limited Performance of Estimated Total Kidney Volume for Follow-up of ADPKD

N. Michoux, Y. Pirson, L. Annet, 2021, Kidney international reports.

Limited performance of estimated total kidney volume for follow-up of autosomal dominant polycystic kidney disease

N. Michoux, Y. Pirson, L. Annet, 2021 .

Autosomal dominant polycystic kidney disease is associated with central and nephrogenic defects in osmoregulation.

J. Haymann, A. Serra, O. Devuyst, 2012, Kidney international.

Lanreotide Reduces Liver Volume, But Might Not Improve Muscle Wasting or Weight Loss, in Patients With Symptomatic Polycystic Liver Disease.

F. Dobbels, F. Nevens, B. Bammens, 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Development and validation of a polycystic liver disease complaint-specific assessment (POLCA).

F. Dobbels, F. Nevens, B. Bammens, 2014, Journal of hepatology.

Safety and efficacy of different lanreotide doses in the treatment of polycystic liver disease: pooled analysis of individual patient data

F. Nevens, B. Bammens, R. Vanslembrouck, 2013, Alimentary pharmacology & therapeutics.

Safety and ef fi cacy of different lanreotide doses in the treatment of polycystic liver disease : pooled analysis of individual patient data

F. Nevens, B. Bammens, R. Vanslembrouck, 2013 .

Night blindness in a haemodialysed ADPKD patient receiving octreotide

Y. Pirson, T. Ho, P. Decleire, 2012, Clinical kidney journal.

Medullary sponge kidney--part of a congenital syndrome.

Y. Pirson, D. Rommel, 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Diagnosis of cyst infection in patients with autosomal dominant polycystic kidney disease: attributes and limitations of the current modalities.

R. Lhommel, F. Jouret, O. Devuyst, 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Positron-emission computed tomography in cyst infection diagnosis in patients with autosomal dominant polycystic kidney disease.

R. Lhommel, F. Jouret, O. Devuyst, 2011, Clinical journal of the American Society of Nephrology : CJASN.

Cholesterol embolism in a renal graft after treatment with streptokinase

Y. Pirson, J. Cosyns, B. Honhon, 1988, British medical journal.

Mutation detection in the repeated part of the PKD1 gene.

J. Saris, M. Breuning, D. Peters, 1997, American journal of human genetics.

Recent advances in the clinical management of autosomal-dominant polycystic kidney disease.

Y. Pirson, 1996, QJM : monthly journal of the Association of Physicians.

Outcome of patients with tuberous sclerosis after renal transplantation.

J. Squifflet, J. Balligand, Y. Pirson, 1990, Transplantation.

Identification of mutations in the alpha 3(IV) and alpha 4(IV) collagen genes in autosomal recessive Alport syndrome.

H. Smeets, C. Antignac, M. Gubler, 1994, Nature genetics.

OUTCOME OF THIRTY PATIENTS WITH ALPORT'S SYNDROME AFTER RENAL TRANSPLANTATION

J. Squifflet, Y. Pirson, J. Grünfeld, 1991, Transplantation.

Incidence of renal failure and nephroprotection by RAAS inhibition in heterozygous carriers of X-chromosomal and autosomal recessive Alport mutations.

R. Torra, Y. Pirson, G. Müller, 2012, Kidney international.

Myocardial revascularization in patients on renal replacement therapy.

Y. Pirson, C. van Ypersele de Strihou, R. Dion, 1991, Clinical nephrology.

Confirmation of the crucial role of the recipient's maximal hydration on early diuresis of the human cadaver renal allograft.

J. Squifflet, Y. Pirson, B. Gribomont, 1983, Transplantation.

MAXIMAL HYDRATION DURING ANESTHESIA INCREASES PULMONARY ARTERIAL PRESSURES AND IMPROVES EARLY FUNCTION OF HUMAN RENAL TRANSPLANTS

J. Squifflet, Y. Pirson, B. Gribomont, 1982, Transplantation.

Identification of current smokers among renal transplant recipients.

M. Jadoul, Y. Pirson, L. Galanti, 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Hepatitis C infection in renal transplant patients: new insights and unanswered questions.

Y. Pirson, E. Goffin, É. Goffin, 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Deterioration in renal function associated with fibrate therapy.

O. Devuyst, Y. Pirson, E. Goffin, 2001, Clinical nephrology.

Purple-blue subcutaneous nodules after renal transplantation: not always Kaposi sarcoma.

Y. Pirson, J. Gigi, E. Goffin, 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Cinacalcet sustainedly prevents pancreatitis in a child with a compound heterozygous SPINK1/AP2S1 mutation.

Y. Pirson, E. Sokal, X. Stephenne, 2019, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

Autosomal recessive Alport syndrome: immunohistochemical study of type IV collagen chain distribution.

C. Antignac, C. Antignac, M. Gubler, 1995, Kidney international.

Outcome of kidney transplantation in type Ioral‐facial‐digital syndrome

K. Dahan, C. Thauvin-Robinet, O. Devuyst, 2011, Transplant international : official journal of the European Society for Organ Transplantation.

Sequential Observation of Fundus Changes in Patients with Long Standing Membranoproliferative Glomerulonephritis Type II (MPGN type II)

Y. Pirson, Y. Vanrenterghem, B. van Damme, 1991, European journal of ophthalmology.

ARE POSTOPERATIVE PULMONARY COMPLICATIONS PREVENTABLE?

J. Squifflet, Y. Pirson, J. Dundee, 1984, The Lancet.

Tacrolimus and low‐dose steroid immunosuppression preserves bone mass after renal transplantation

J. Squifflet, Y. Pirson, J. Devogelaer, 2002 .

Tacrolimus and low-dose steroid immunosuppression preserves bone mass after renal transplantation

J. Squifflet, Y. Pirson, J. Devogelaer, 2002, Transplant international : official journal of the European Society for Organ Transplantation.

Genetics of hypercalciuric stone forming diseases.

O. Devuyst, Y. Pirson, 2007, Kidney international.

Autosomal-dominant periodic fever with AA amyloidosis: Novel mutation in tumor necrosis factor receptor 1 gene Rapid Communication.

M. Jadoul, D. Abramowicz, Y. Pirson, 2001, Kidney international.

J. Squifflet, Y. Pirson, M. Mourad, 1997, Transplantation proceedings.

Outcome of HCV infection after renal transplantation.

J. Squifflet, Y. Pirson, C. van Ypersele de Strihou, 1994, Kidney international.

Acute hepatitis B infection after vaccination

A. Zuckerman, Y. Pirson, E. Goffin, 1995, The Lancet.

Kidney and kidney-pancreas transplantation in diabetic recipients.

J. Squifflet, Y. Pirson, B. Vandeleene, 2000, Diabetes & metabolism.

Captopril and renal insufficiency.

Y. Pirson, M. Demeyer, G. Alexandre, 1983, The New England journal of medicine.

Paradoxical response to furosemide in uromodulin-associated kidney disease.

K. Dahan, O. Devuyst, Y. Pirson, 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Outcome of kidney transplantation in familial juvenile hyperuricaemic nephropathy.

Y. Pirson, L. Labriola, Kar in Dahan, 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Fabry nephropathy: indications for screening and guidance for diagnosis and treatment by the European Renal Best Practice.

C. Wanner, W. van Biesen, A. Ortiz, 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Present experiences in a series of 26 ABO-incompatible living donor renal allografts.

J. Squifflet, Y. Pirson, D. Latinne, 1987, Transplantation proceedings.

Benign monoclonal gammopathy turning to AL amyloidosis after kidney transplantation.

L. Michaux, C. Hermans, Y. Pirson, 1999, American Journal of Kidney Diseases.

The diabetic patient with ESRD: how to select the modality of renal replacement.

Y. Pirson, 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Is peritoneal dialysis a suitable renal replacement therapy in autosomal dominant polycystic kidney disease?

Y. Pirson, E. Goffin, 2009, Nature Clinical Practice Nephrology.

De novo membranous nephropathy in human renal allografts: report of nine patients.

J. Squifflet, V. Pinn, Y. Pirson, 1982, Kidney international.

Rituximab for minimal-change nephrotic syndrome in adulthood: predictive factors for response, long-term outcomes and tolerance.

E. Daugas, D. Chauveau, Y. Pirson, 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Ultrastructural immunoenzymatic study of alpha-fetoprotein-producing cells in the human fetal liver.

Y. Pirson, J. Chayvialle, S. Peyrol, 1977, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Factor H, membrane cofactor protein, and factor I mutations in patients with hemolysis, elevated liver enzymes, and low platelet count syndrome.

A. Benachi, B. Knebelmann, Y. Pirson, 2008, Blood.

Effect of renal transplantation on the radiological signs of dialysis amyloid osteoarthropathy.

B. Maldague, M. Jadoul, Y. Pirson, 1989, Clinical nephrology.

ADPKD-associated intracranial aneurysm: new insights and unanswered questions.

D. Chauveau, Y. Pirson, 1995, Contributions to nephrology.

Repeated renal failure with use of captopril in a cystinotic renal allograft recipient

Y. Pirson, J. De Plaen, C. van Ypersele, 1983 .

Prevalence and causes of hypertension late after renal transplantation.

P. Vereerstraeten, P. Kinnaert, Y. Pirson, 1983, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association.

Splenectomy As a Prerequisite for Successful Human Abo-incompatible Renal-transplantation

J. Squifflet, Y. Pirson, D. Latinne, 1985 .

Which type of dialysis in patients with cholesterol crystal embolism?

C. Sempoux, O. Devuyst, Y. Pirson, 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Early postoperative monitoring of natural anti-A and anti-B isoantibodies in ABO-incompatible living donor renal allografts.

J. Squifflet, Y. Pirson, D. Latinne, 1987, Transplantation proceedings.

Creatinine rise after fibrate therapy in renal graft recipients

O. Devuyst, Y. Pirson, E. Goffin, 1993, The Lancet.

Interaction Between Sibutramine and Cyclosporine

Y. Pirson, E. Goffin, Gaëtan Clerbaux, 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Subarachnoid haemorrhage in ADPKD patients: how to recognize and how to manage?

J. van Gijn, D. Chauveau, Y. Pirson, 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

The fate of second kidney transplant after recurrence of glomerulonephritis in the first transplant

J. Squifflet, Y. Pirson, C. Pouteil‐Noble, 1997 .

Epiphyseal impaction as a cause of severe osteoarticular pain of lower limbs after renal transplantation.

B. Maldague, Y. Pirson, C. van Ypersele de Strihou, 1993, Kidney international.

Y. Pirson, P. Gianello, J. Squifflet, 1990, Transplant international : official journal of the European Society for Organ Transplantation.

Hemolytic Uremic Syndrome and Thrombotic Thrombocytopenic Purpura

Y. Pirson, J. Collard, C. Brohet, 1993 .

ADVANCES IN GENETIC DISEASES OF THE KIDNEY: IMPACT ON RENAL MEDICINE

Y. Pirson, 2007, Acta clinica Belgica.

Post-renal transplant syndrome of transient lower limb joint pain: description under a tacrolimus-based immunosuppression.

J. Squifflet, Y. Pirson, J. Devogelaer, 2003, Clinical nephrology.

CF gene and cystic fibrosis transmembrane conductance regulator expression in autosomal dominant polycystic kidney disease.

P. Gabow, O. Devuyst, G. Brosnahan, 2000, Journal of the American Society of Nephrology : JASN.

Complement activation and effect of eculizumab in scleroderma renal crisis

M. Jadoul, Y. Pirson, P. Stordeur, 2016, Medicine.

A cluster of mutations in the UMOD gene causes familial juvenile hyperuricemic nephropathy with abnormal expression of uromodulin.

D. Vertommen, K. Dahan, C. Antignac, 2003, Journal of the American Society of Nephrology : JASN.

Familial juvenile hyperuricemic nephropathy and autosomal dominant medullary cystic kidney disease type 2: two facets of the same disease?

K. Dahan, F. Hildebrandt, Y. Pirson, 2001, Journal of the American Society of Nephrology : JASN.

Comment Mettre Au Point Une Lithiase Urinaire

Y. Pirson, 1985 .

Ganciclovir for Cytomegalo-virus Infection in Renal-transplant Recipients

Jp. Squifflet, Yves Pirson, Pierre Gianello, 1989 .

The peroperative management in multiple organ donors: a crucial phase in organ transplantation.

J. Squifflet, Y. Pirson, J. Rubay, 1986, Acta anaesthesiologica Belgica.

Successful Long-term Preservation of Human Cadaver Renal-allografts With Euro-collins Solution

Y. Pirson, J. Jamart, P. Gianello, 1984 .

Safe preservation of human renal cadaver transplants by Euro-Collins solution up to 50 hours.

J. Squifflet, Y. Pirson, P. Gianello, 1981, Transplantation proceedings.

Re: Effect of furosemide on dialysis requirement following cadaveric kidney transplantation.

J. Squifflet, Y. Pirson, P. Gianello, 1988, The Journal of urology.

ABO-Incompatibility and Organ Transplantation

J. Squifflet, Y. Pirson, D. Latinne, 1991 .

Lamivudine inhibits hepatitis B virus replication in kidney graft recipients.

J. Squifflet, Y. Pirson, Y. Horsmans, 1998, Transplantation.

Genetic studies into inherited and sporadic hemolytic uremic syndrome.

J. Goodship, Y. Pirson, P. Turnpenny, 1998, Kidney international.

Acute necrotico-hemorrhagic pancreatitis after famciclovir prescription.

Y. Pirson, C. van Ypersele de Strihou, Y. Horsmans, 1995, Transplantation.

Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

B. Kasiske, D. Wheeler, R. Gansevoort, 2015, Kidney international.

Mutations in SEC63 cause autosomal dominant polycystic liver disease

P. Kamath, R. Lifton, S. Somlo, 2004, Nature Genetics.

Isolated polycystic liver disease as a distinct genetic disease, unlinked to polycystic kidney disease 1 and polycystic kidney disease 2

M. Breuning, D. Peters, Y. Pirson, 1996, Hepatology.

Lessons learned from ABO-incompatible living donor kidney transplantation: 20 years later.

J. Squifflet, Y. Pirson, D. Latinne, 2004, Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation.

Human ABO-incompatible living donor renal homografts.

J. Squifflet, Y. Pirson, D. Latinne, 1985, The Netherlands journal of medicine.

A homozygous mutation in INVS causing juvenile nephronophthisis with abnormal reactivity of the Wnt/beta-catenin pathway.

K. Dahan, O. Devuyst, Y. Pirson, 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Identification of a locus for autosomal dominant polycystic liver disease, on chromosome 19p13.2-13.1.

C. Falk, P. Kamath, S. Somlo, 2000, American journal of human genetics.

Drugs potentiating cyclosporin nephrotoxicity.

M. Jadoul, Y. Pirson, C. van Ypersele de Strihou, 1991, Nephron.

Late urinary tract infection after transplantation: prevalence, predisposition and morbidity.

Y. Pirson, C. van Ypersele de Strihou, R. Cuvelier, 1985, Nephron.

Renal side effects of nonsteroidal antiinflammatory drugs: clinical relevance.

Y. Pirson, C. van Ypersele de Strihou, C. V. Strihou, 1986, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Massive amoxycillin crystalluria causing anuric acute renal failure.

M. Jadoul, Y. Pirson, L. Labriola, 2003, Clinical nephrology.

Management of cerebral aneurysms in autosomal dominant polycystic kidney disease.

V. Torres, D. Chauveau, Y. Pirson, 2002, Journal of the American Society of Nephrology : JASN.

Multiple thoracic paraspinal meningeal cysts in autosomal dominant polycystic kidney disease.

G. Cosnard, E. Coche, Y. Pirson, 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Anesthetic protocol in human renal transplantation: twenty-two years of experience.

J. Squifflet, Y. Pirson, B. Gribomont, 1986, Acta anaesthesiologica Belgica.

Making the diagnosis of Alport's syndrome.

Y. Pirson, 1999, Kidney international.

Atypical Haemolytic Uraemic Syndrome Associated with a Hybrid Complement Gene

M. Jackson, J. Goodship, J. Venables, 2006, PLoS medicine.

Identification of mutations in the α3(IV) and α4(IV) collagen genes in autosomal recessive Alport syndrome

H. Smeets, C. Antignac, M. Gubler, 1994, Nature Genetics.

Does TNF-alpha enhance cystogenesis in ADPKD?

Y. Pirson, 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Autosomal recessive polycystic kidney disease in adulthood.

D. Chauveau, Y. Pirson, J. Grünfeld, 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Renal transplantation in tuberous sclerosis.

Y. Pirson, 1992, BMJ.

COURSE OF HENOCH‐SCHÖNLEIN NEPHRITIS AFTER RENAL TRANSPLANTATION: REPORT ON TEN PATIENTS AND REVIEW OF THE LITERATURE

J. Squifflet, Y. Pirson, J. Cosyns, 1994, Transplantation.

Retardation of fetal growth in patients receiving immunosuppressive therapy.

Y. Pirson, C. van Ypersele de Strihou, M. van Lierde, 1985, The New England journal of medicine.

Indications for dialysis and transplantation in end-stage renal disease.

Y. Pirson, C. van Ypersele de Strihou, 1989, Contributions to nephrology.

[Renal-transplantation in Amyloidosis]

Y. Pirson, J. Cosyns, J. Squifflet, 1986 .

X-linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a "European Community Alport Syndrome Concerted Action" study.

H. Smeets, J. Jais, M. Sanak, 2003, Journal of the American Society of Nephrology : JASN.

X-linked Alport syndrome: natural history in 195 families and genotype- phenotype correlations in males.

H. Smeets, J. Jais, M. Sanak, 2000, Journal of the American Society of Nephrology : JASN.

Renal transplantation in autosomal dominant polycystic kidney disease

O. Devuyst, Y. Pirson, N. Kanaan, 2014, Nature Reviews Nephrology.

Two kidney-transplant women with therapy-resistant hypertension: diagnostic error of a renal artery stenosis.

Y. Pirson, P. Goffette, Gaëtan Clerbaux, 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome

J. Goodship, R. Decorte, J. Atkinson, 2003, Proceedings of the National Academy of Sciences of the United States of America.

Recurrent fulminant anti-glomerular basement membrane nephritis at a 7-year interval.

Y. Pirson, J. Cosyns, G. Loute, 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Recurrence and graft loss after kidney transplantation for henoch-schonlein purpura nephritis: a multicenter analysis.

E. Thervet, Y. Pirson, Y. Vanrenterghem, 2011, Clinical journal of the American Society of Nephrology : CJASN.

Mycotic aneurysm of renal graft artery: diagnosis by ultrasonography.

J. Squifflet, Y. Pirson, C. van Ypersele de Strihou, 1983, Urology.

Treatment of renal graft artery stenosis. Comparison between surgical bypass and percutaneous transluminal angioplasty.

J. Squifflet, Y. Pirson, C. van Ypersele de Strihou, 1989, Transplantation.

Recurrence of membranous nephropathy after renal transplantation: probability, outcome and risk factors.

J. Squifflet, Y. Pirson, C. Pouteil‐Noble, 1998, Clinical nephrology.

[Lymphocele Following Renal-transplantation]

J. Squifflet, Y. Pirson, J. Rubay, 1983 .

Recurrence of de novo graft membranous glomerulonephritis.

Y. Pirson, J. Cosyns, G. Alexandre, 1981, Nephron.

CYCLOSPORIN-DILTIAZEM INTERACTION

Y. Pirson, J. Pochet, 1986, The Lancet.

Haemodialysis and transplantation in Wegener's granulomatosis.

Y. Pirson, C. van Ypersele de Strihou, J. Vandenbroucke, 1979, British medical journal.

Carbohydrate antigen 19-9 as a diagnostic marker for hepatic cyst infection in autosomal dominant polycystic kidney disease.

O. Devuyst, Y. Pirson, N. Kanaan, 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Extrarenal manifestations of autosomal dominant polycystic kidney disease.

Y. Pirson, 2010, Advances in chronic kidney disease.

Complications of autosomal dominant polycystic kidney disease in 50 haemodialysed patients. A case-control study. The U.C.L. Collaborative Group.

Y. Pirson, C. van Ypersele de Strihou, J. Christophe, 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Outcome of renal replacement therapy in autosomal dominant polycystic kidney disease.

Y. Pirson, J. Christophe, É. Goffin, 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Extrarenal manifestations in autosomal dominant polycystic kidney disease.

D. Chauveau, Y. Pirson, J. Grünfeld, 1997, Advances in nephrology from the Necker Hospital.

Intracranial aneurysms in autosomal dominant polycystic kidney disease.

D. Chauveau, Y. Pirson, J. Grünfeld, 1994, Kidney international.

European ADPKD Forum multidisciplinary position statement on autosomal dominant polycystic kidney disease care

A. Kent, R. Vanholder, R. Gansevoort, 2017, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[Lymphoceles after renal transplantation].

J. Squifflet, Y. Pirson, J. Rubay, 1983, Journal de chirurgie.

Outcome of cadaver kidney transplantation in 23 patients with type 2 diabetes mellitus.

J. Squifflet, Y. Pirson, Y. Vanrenterghem, 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Mapping of the gene for autosomal recessive polycystic kidney disease (ARPKD) to chromosome 6p21–cen

B. Wirth, V. Steinbicker, K. Zerres, 1994, Nature Genetics.

Comparison between siblings and twins supports a role for modifier genes in ADPKD.

X. Lens, M. Breuning, O. Devuyst, 2004, Kidney international.

BTI-322 for induction therapy after renal transplantation: a randomized study.

J. Squifflet, J. Hope, Y. Pirson, 1997, Transplantation proceedings.

BTI-322 for acute rejection after renal transplantation.

J. Squifflet, J. Hope, Y. Pirson, 1997, Transplantation proceedings.

Prevention of rejection with BTI-322 after renal transplantation (results at 9 months).

J. Squifflet, J. Hope, Y. Pirson, 1997, Transplantation proceedings.

FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia

I. Macdougall, E. Daugas, K. Eckardt, 2014, Nephrology, Dialysis and Transplantation.

Bilateral ureteral endometriosis with end-stage renal failure.

J. Squifflet, Y. Pirson, J. Cosyns, 1987, Urology.

The Need for Pretransplant Pathologic Examination in Cadaver Donor Segmental Pancreas Transplantation

J. Squifflet, Y. Pirson, B. Vandeleene, 1984 .

[Potentialisation of hyperkalemia effects by cinacalcet-induced hypocalcemia on dialysis].

Y. Pirson, B. Flamion, F. Simon, 2012, Nephrologie & therapeutique.

Hemolytic uremic syndrome in three adult siblings: a familial study and evolution.

Y. Pirson, C. van Ypersele de Strihou, C. Lefebvre, 1987, Clinical nephrology.

No clinically significant interaction between ciclosporin and isradipine.

Y. Pirson, C. van Ypersele de Strihou, P. Wallemacq, 1991, Nephron.

Building a network of ADPKD reference centres across Europe: the EuroCYST initiative.

A. Köttgen, G. Remuzzi, R. Gansevoort, 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Evaluation in patients with Alport syndrome of knowledge of the disease and attitudes toward prenatal diagnosis.

B. Boudailliez, Y. Pirson, A. Moynot, 1994, Clinical nephrology.

Clinical and mutational spectrum of hypoparathyroidism, deafness and renal dysplasia syndrome

K. Dahan, Y. Pirson, V. Benoit, 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Recurrent corneal erosion associated with Alport's syndrome. Rapid communication.

Y. Pirson, B. Snyers, C. Rhys, 1997, Kidney international.

Osteoporosis after organ transplantation

Y. Pirson, G. Depresseux, J. Squifflet, 2001, The Lancet.

Malakoplakia of the caecum in a kidney‐transplant recipient: presentation as acute tumoral perforation and fatal outcome

O. Ciccarelli, T. Berney, Y. Pirson, 1999 .

Malakoplakia of the caecum in a kidney-transplant recipient: presentation as acute tumoral perforation and fatal outcome

J. Squifflet, O. Ciccarelli, T. Berney, 1999, Transplant international : official journal of the European Society for Organ Transplantation.

Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy.

T. Friede, J. Ehrich, H. Anders, 2012, Kidney international.

Association of PKD2 (polycystin 2) mutations with left-right laterality defects.

K. Dahan, O. Devuyst, Y. Pirson, 2011, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Antiglomerular basement membrane nephritis induced by IgA1 antibodies.

J. Hamels, Y. Pirson, P. Gris, 1991, Nephron.

Early diagnosis of CMV infection by detection of pp 65 antigen in 91 renal transplant recipients

Y. Pirson, M. Vargas, J. Squifflet, 1994 .

Early diagnosis of CMV infection by detection of pp65 antigen in 91 renal transplant recipients

J. Squifflet, Y. Pirson, M. Vargas, 1994, Transplant international : official journal of the European Society for Organ Transplantation.

Cyclosporin A and osteonecrosis of the femoral head.

J. Squifflet, Y. Pirson, P. Gianello, 1988, The Journal of bone and joint surgery. American volume.

Implications of chronic hepatitis B or hepatitis C infection for renal transplant candidates.

Y. Pirson, C. van Ypersele de Strihou, É. Goffin, 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Kidney transplantation in patients with Wilms' tumor.

J. Squifflet, Y. Pirson, C. van Ypersele de Strihou, 1992, Transplantation.

Combined heart-kidney transplantation: report on six cases.

Y. Pirson, P. Noirhomme, L. Jacquet, 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Outcome of hepatitis B and C virus‐associated hepatocellular carcinoma occurring after renal transplantation

M. Jadoul, Y. Pirson, I. Borbath, 2017, Journal of viral hepatitis.

D-penicillamine induced crescentic glomerulonephritis: report and review of the literature.

Y. Pirson, S. Brichard, J. Devogelaer, 1987, Journal of Rheumatology.

GANCICLOVIR FOR CYTOMEGALOVIRUS INFECTION IN RENAL TRANSPLANT RECIPIENTS

Y. Pirson, M. Reynaert, P. Gianello, 1989, The Lancet.

Treatment of cytomegalovirus pneumonitis with ganciclovir in renal transplantation

Y. Pirson, P. Gianello, J. Squifflet, 1988, Transplant International.

Acute abdominal pain and chills in an ADPKD transplant recipient

Y. Pirson, E. Danse, N. Kanaan, 2010, NDT plus.

Calcineurin Inhibitors Downregulate HNF-1&bgr; and May Affect the Outcome of HNF1B Patients After Renal Transplantation

N. Chassaing, J. Schanstra, L. Rostaing, 2016, Transplantation.

Erratum: Building a network of ADPKD reference centres across Europe: the EuroCYST initiative(Nephrology Dialysis Transplantation) (2014) 29 :suppl 4 (iv26-iv32) doi: 10.1093/ndt/gfu091)

A. Köttgen, G. Remuzzi, R. Gansevoort, 2014 .

Mild chronic renal failure with a family history of kidney disease

K. Dahan, O. Devuyst, Y. Pirson, 2009, NDT plus.

Influence of ACE (I/D) and G460W polymorphism of alpha-adducin in autosomal dominant polycystic kidney disease.

O. Devuyst, D. Chauveau, Y. Pirson, 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

International Multi-Specialty Delphi Survey: Identification of Diagnostic Criteria for Hepatic and Renal Cyst Infection

W. Oyen, F. Nevens, G. Rangan, 2016, Nephron.

Hepatitis and renal transplants.

J. Najarian, C. Ponticelli, C. Kjellstrand, 1977, The New England journal of medicine.

Late-onset renal failure in Senior-Loken syndrome.

K. Dahan, Y. Pirson, J. Cosyns, 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Haemodialysis or renal transplantation in the treatment of end-stage diabetic nephropathy.

J. Squifflet, Y. Pirson, C. van Ypersele de Strihou, 1983, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association.

[Physiopathology of diabetic nephropathy: what we learn from transplantation].

Y. Pirson, 1998, Nephrologie.

[Pathophysiology of diabetic nephropathy: what has been learned from clinical transplantation]

Y. Pirson, 1998 .

Ischemic necrosis of the allograft ureter.

J. Squifflet, Y. Pirson, P. Gianello, 1984, Transplantation proceedings.

Postoperative continuous positive airway pressure helps to prevent pulmonary infection after human renal transplantation.

J. Squifflet, Y. Pirson, P. Cordier, 1984, Transplantation proceedings.

[Kidney transplantation in a case of amyloidosis].

Y. Pirson, C. van Ypersele de Strihou, J. Cosyns, 1986, Nephrologie.

Fundus changes in membranoproliferative glomerulonephritis type II

Y. Pirson, Y. Vanrenterghem, M. Leys, 1991, Graefe's Archive for Clinical and Experimental Ophthalmology.

Cyclosporine-steroids versus conventional therapy in cadaver kidney transplantation: analysis of a randomized trial at two years.

J. Squifflet, Y. Pirson, P. Gianello, 1987, Transplantation Proceedings.

International Multi-Specialty Delphi Survey: Identification of Diagnostic Criteria for Hepatic and Renal Cyst Infection.

W. Oyen, F. Nevens, G. Rangan, 2016, Nephron.

Cyst number but not the rate of cystic growth is associated with the mutated gene in autosomal dominant polycystic kidney disease.

F. Cosio, J. Miller, K. Bae, 2006, Journal of the American Society of Nephrology : JASN.

Cyclosporine-methyltestosterone interaction.

Y. Pirson, C. van Ypersele de Strihou, A. Geubel, 1991, Nephron.

Effect of 9-(2-hydroxy-1-[hydroxymethyl] ethoxymethyl) guanine (DHPG) on cytomegalovirus pneumonitis after renal transplantation.

Y. Pirson, P. Gianello, J. Squifflet, 1988, Transplantation.

[Renal fibromuscular dysplasia and cerebral aneurysm in a hypertensive patient with a familial history of cerebral vascular complications].

Y. Pirson, A. Persu, J. De Plaen, 1997, Presse medicale.

Paradoxical response to furosemide in uromodulin-associated kidney disease.

K. Dahan, O. Devuyst, Y. Pirson, 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Phenotype and outcome in hereditary tubulointerstitial nephritis secondary to UMOD mutations.

K. Dahan, C. Antignac, D. Lacombe, 2011, Clinical journal of the American Society of Nephrology : CJASN.

European ADPKD Forum multidisciplinary position statement on autosomal dominant polycystic kidney disease care European ADPKD Forum and Multispecialist Roundtable participants

R. Vanholder, D. Peters, A. Ong, 2018 .

Distal lower limb bone pain after renal transplantation.

Y. Pirson, C. van Ypersele de Strihou, B. Vande Berg, 1996, Transplantation.

Incidence of renal failure and nephroprotection by RAAS inhibition in heterozygous carriers of X-chromosomal and autosomal recessive Alport mutations.

R. Torra, Y. Pirson, G. Müller, 2012, Kidney international.

Does TNF-alpha enhance cystogenesis in ADPKD?

Y. Pirson, 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.